Answer
Orkambi is contraindicated in people with hypersensitivity to its active substances, lumacaftor or ivacaftor, or any excipient listed in section 6.1.
Sources for this answer
- Orkambi 200 mg/125 mg film coated tabletsVertex Pharmaceuticals (Europe) Limited · emc · SmPC §4.3 Contraindications · Version 19Document updated
Sources checked